Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD) |
RAS-T093 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Igg Antibody Laboratories manufactures the ssa/ro antibody igg titer reagents distributed by Genprice. The Ssa/Ro Antibody Igg Titer reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Ssa/Ro products are available in stock. Specificity: Ssa/Ro Category: Antibody Group: Igg Titer
Human Anti-PD-1 Antibody IgG Titer Serologic ELISA Assay Kit |
ACROBIOSYSTEMS |
96tests |
EUR 470.8 |
|
Description: Programmed cell death protein 1 (PD-1) is an inhibitory receptor that is expressed on some tumor cells and causes down regulation of the immune system by reducing T-cell activity. Anti-PD-1 monoclonal antibodies block the PD-1 receptor so the T cells are no longer inhibited and therefore activates the immune response against the tumor. |
SARS-CoV-2 Total IgG Antibody Titer Assay Kit (Spike RBD) |
MyBiosource |
5x96Tests |
EUR 3465 |
SARS-CoV-2 Total IgG Antibody Titer Assay Kit (Spike RBD) |
MyBiosource |
96Tests |
EUR 750 |
Sheep anti human PSA IgG fraction, high titer |
MyBiosource |
0.1mg |
EUR 460 |
Sheep anti human PSA IgG fraction, high titer |
MyBiosource |
1mg |
EUR 2905 |
Sheep anti human PSA IgG fraction, high titer |
MyBiosource |
5x1mg |
EUR 12835 |
Rabbit anti human prorenin IgG fraction, high titer |
MyBiosource |
0.1mg |
EUR 500 |
Igg Titer information
Monkey Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (Spike Trimer) |
RAS-T046 |
ACROBIOSYSTEMS |
96tests |
EUR 631.3 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide. The SARS-CoV-2 pandemic presents an extraordinary challenge to the lives and health of the global population, resulting in a total of over 200 million diagnosed cases and 4.9 million death (as of October 2021). It also significantly affected the social, economic and environmental domains throughout the world and changed everyone’s life. ACROBiosystems, a leading life science company dedicated to aid the global COVID-19 response,developed different kits suitable for serum antibody detection in different species (Mouse, Monkeys, humans) to meet the needs of preclinical and clinical experiments. |
Anti Human PAI-1 IgG fraction - high titer |
MBS480205-01mg |
MyBiosource |
0.1mg |
EUR 790 |
Anti Human PAI-1 IgG fraction - high titer |
MBS480205-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3315 |
Anti-SARS-CoV-2 (B.1.351) Antibody IgG Titer Serologic Assay Kit (Spike Trimer) |
RAS-T030 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: It's been reported that coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-SARS-CoV-2 (B.1.617.2) Antibody IgG Titer Serologic Assay Kit (Spike Trimer) |
RAS-T043 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. The variant B.1.1.7 identified in the United Kingdom (UK) carries a large number of mutations and is reported to spread more easily and quickly than other variants. The variant B.1.351 identified in South Africa ,P.1 identified in Brazil and B.1.617.2 in India show evidence of increased transmissibility and resistance to established immunity. A common mutation identified in the U.K, South African and Brazilian variants is N501Y, and the mutation identified in B.1.617.2 is T478K,which resides on the receptor-binding domain (RBD) of SARS-CoV-2 spike protein. To evaluate the impacts of the new variants, a rapid and effective assay kit detecting the levels of antibody against the mutant is in urgent need. |
Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG Titer Serologic Assay Kit (Spike Trimer) |
RAS-T058 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Anti-SARS-CoV-2 (B.1.1.7) Antibody IgG Titer Serologic Assay Kit (Spike Trimer) |
RAS-T027 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: It's been reported that coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-SARS-CoV-2 (P.1) Antibody IgG Titer Serologic Assay Kit (Spike Trimer) |
RAS-T033 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: It's been reported that coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Sheep anti human PSA IgG fraction, high titer |
MBS135203-01mg |
MyBiosource |
0.1mg |
EUR 460 |
Sheep anti human PSA IgG fraction, high titer |
MBS135203-1mg |
MyBiosource |
1mg |
EUR 2905 |
Sheep anti human PSA IgG fraction, high titer |
MBS135203-5x1mg |
MyBiosource |
5x1mg |
EUR 12835 |
Ro(SSA) Antibody |
33238-05111 |
AssayPro |
150 ug |
EUR 215 |
Mouse Anti-SARS-CoV-2 (B.1.1.529) Antibody IgG Titer Serologic Assay Kit (Spike S1) |
RAS-T061 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility. To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Mouse Anti-SARS-CoV-2 (B.1.351) Antibody IgG Titer Serologic Assay Kit (Spike S1) |
RAS-T084 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Mouse Anti-SARS-CoV-2 (B.1.617.2) Antibody IgG Titer Serologic Assay Kit (Spike S1) |
RAS-T086 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Mouse Anti-SARS-CoV-2 (B.1.1.7) Antibody IgG Titer Serologic Assay Kit (Spike S1) |
RAS-T083 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
Mouse Anti-SARS-CoV-2 (P.1) Antibody IgG Titer Serologic Assay Kit (Spike S1) |
RAS-T085 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |